4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-030483
Chief Medical Officer sold 2,615 shares at an average $25.65 ($67,082)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-03-11 | Sale 10b5-1 | −1,585 | $25.70 | $40,735 | 151,590 | D |
| Farwell Wildon Chief Medical Officer | 2024-03-12 | Sale 10b5-1 | −1,030 | $25.58 | $26,347 | 150,560 | D |
| Open-market sales · 2,615 sh · avg $25.65 · $67,082 | |||||||
Loading xslF345X05/ownership.xml…